142 related articles for article (PubMed ID: 17518612)
21. Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer.
Hattori T; Kokura S; Okuda T; Okayama T; Takagi T; Handa O; Naito Y; Yoshida N; Yoshikawa T
Int J Hyperthermia; 2007 Nov; 23(7):591-8. PubMed ID: 18038289
[TBL] [Abstract][Full Text] [Related]
22. Oncolytic herpes simplex virus treatment of metastatic breast cancer.
Wang J; Hu P; Zeng M; Rabkin SD; Liu R
Int J Oncol; 2012 Mar; 40(3):757-63. PubMed ID: 22108767
[TBL] [Abstract][Full Text] [Related]
23. Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy.
Workenhe ST; Pol JG; Lichty BD; Cummings DT; Mossman KL
Cancer Immunol Res; 2013 Nov; 1(5):309-19. PubMed ID: 24777969
[TBL] [Abstract][Full Text] [Related]
24. Enhanced efficacy of herpes simplex virus mutant HF10 combined with paclitaxel in peritoneal cancer dissemination models.
Shimoyama S; Goshima F; Teshigahara O; Kasuya H; Kodera Y; Nakao A; Nishiyama Y
Hepatogastroenterology; 2007 Jun; 54(76):1038-42. PubMed ID: 17629034
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy.
Errington F; Bateman A; Kottke T; Thompson J; Harrington K; Merrick A; Hatfield P; Selby P; Vile R; Melcher A
Clin Cancer Res; 2006 Feb; 12(4):1333-41. PubMed ID: 16489091
[TBL] [Abstract][Full Text] [Related]
26. An immunocompetent murine model for oncolysis with an armed and targeted measles virus.
Ungerechts G; Springfeld C; Frenzke ME; Lampe J; Parker WB; Sorscher EJ; Cattaneo R
Mol Ther; 2007 Nov; 15(11):1991-7. PubMed ID: 17712331
[TBL] [Abstract][Full Text] [Related]
27. Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy.
Hoffmann D; Wildner O
Mol Cancer Ther; 2006 Aug; 5(8):2013-22. PubMed ID: 16928822
[TBL] [Abstract][Full Text] [Related]
28. Oncolytic herpes virus induces effective anti-cancer immunity against murine colon cancer.
Shirota T; Kasuya H; Kodera Y; Nishikawa Y; Shikano T; Sahin TT; Gewen T; Yamamura K; Fukuda S; Kanzaki A; Yamada S; Fujii T; Sugimoto H; Nomoto S; Takeda S; Nakao A
Hepatogastroenterology; 2011; 58(110-111):1482-9. PubMed ID: 21940320
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography of herpes simplex virus 1 oncolysis.
Kuruppu D; Brownell AL; Zhu A; Yu M; Wang X; Kulu Y; Fuchs BC; Kawasaki H; Tanabe KK
Cancer Res; 2007 Apr; 67(7):3295-300. PubMed ID: 17409438
[TBL] [Abstract][Full Text] [Related]
30. Immune-mediated anti-neoplastic effect of intratumoral RSV envelope glycoprotein expression is related to apoptotic death of tumor cells but not to the size of syncytia.
Hoffmann D; Grunwald T; Bayer W; Wildner O
World J Gastroenterol; 2008 Mar; 14(12):1842-50. PubMed ID: 18350621
[TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect.
Kolodkin-Gal D; Edden Y; Hartshtark Z; Ilan L; Khalaileh A; Pikarsky AJ; Pikarsky E; Rabkin SD; Panet A; Zamir G
Gene Ther; 2009 Jul; 16(7):905-15. PubMed ID: 19440231
[TBL] [Abstract][Full Text] [Related]
32. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.
Chakraborty M; Abrams SI; Coleman CN; Camphausen K; Schlom J; Hodge JW
Cancer Res; 2004 Jun; 64(12):4328-37. PubMed ID: 15205348
[TBL] [Abstract][Full Text] [Related]
33. Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells.
Israyelyan AH; Melancon JM; Lomax LG; Sehgal I; Leuschner C; Kearney MT; Chouljenko VN; Baghian A; Kousoulas KG
Hum Gene Ther; 2007 May; 18(5):457-73. PubMed ID: 17536976
[TBL] [Abstract][Full Text] [Related]
34. Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus.
Diaconu I; Cerullo V; Hirvinen ML; Escutenaire S; Ugolini M; Pesonen SK; Bramante S; Parviainen S; Kanerva A; Loskog AS; Eliopoulos AG; Pesonen S; Hemminki A
Cancer Res; 2012 May; 72(9):2327-38. PubMed ID: 22396493
[TBL] [Abstract][Full Text] [Related]
35. Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.
Boozari B; Mundt B; Woller N; Strüver N; Gürlevik E; Schache P; Kloos A; Knocke S; Manns MP; Wirth TC; Kubicka S; Kühnel F
Gut; 2010 Oct; 59(10):1416-26. PubMed ID: 20675696
[TBL] [Abstract][Full Text] [Related]
36. Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.
Fernández-Ulibarri I; Hammer K; Arndt MA; Kaufmann JK; Dorer D; Engelhardt S; Kontermann RE; Hess J; Allgayer H; Krauss J; Nettelbeck DM
Int J Cancer; 2015 May; 136(9):2228-40. PubMed ID: 25303768
[TBL] [Abstract][Full Text] [Related]
37. Dichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma.
Li C; Meng G; Su L; Chen A; Xia M; Xu C; Yu D; Jiang A; Wei J
Oncotarget; 2015 Jan; 6(3):1544-55. PubMed ID: 25575816
[TBL] [Abstract][Full Text] [Related]
38. A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy.
Kawano H; Komaba S; Kanamori T; Kaneda Y
BMC Med; 2007 Sep; 5():28. PubMed ID: 17883878
[TBL] [Abstract][Full Text] [Related]
39. Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis.
Kulu Y; Kawasaki H; Donahue JM; Kasuya H; Cusack JC; Choi EW; Kuruppu DK; Fuchs BC; Tanabe KK
Cancer Gene Ther; 2013 Feb; 20(2):133-40. PubMed ID: 23348635
[TBL] [Abstract][Full Text] [Related]
40. A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model.
Yoneyama S; Okaji Y; Tsuno NH; Kawai K; Yamashita H; Tsuchiya T; Yamada J; Sunami E; Osada T; Kitayama J; Takahashi K; Nagawa H
Eur J Surg Oncol; 2007 Dec; 33(10):1191-8. PubMed ID: 17314028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
